These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15177224)

  • 1. [Acceptability of misoprostol at home for voluntary drug-induced abortion. Gynécol Obstét Fertil 2004; 32 : 26-33].
    Faucher P
    Gynecol Obstet Fertil; 2004 May; 32(5):472-3. PubMed ID: 15177224
    [No Abstract]   [Full Text] [Related]  

  • 2. Acceptability of home-use of misoprostol in medical abortion.
    Fiala C; Winikoff B; Helström L; Hellborg M; Gemzell-Danielsson K
    Contraception; 2004 Nov; 70(5):387-92. PubMed ID: 15504378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone and misoprostol for early abortion.
    JNMA J Nepal Med Assoc; 2006; 45(161):I. PubMed ID: 17160090
    [No Abstract]   [Full Text] [Related]  

  • 4. [The efficacy and acceptability of voluntary interruption of pregnancy by medication without hospitalization in a city hospital: a prospective study of 433 patients].
    Aubény E
    Gynecol Obstet Fertil; 2005 Sep; 33(9):727-8; author reply 731-2. PubMed ID: 16126431
    [No Abstract]   [Full Text] [Related]  

  • 5. Misoprostol alone for early abortion: an evaluation of seven potential regimens.
    Katz AI; Cremer M
    Contraception; 2006 Aug; 74(2):176; author reply 176-7. PubMed ID: 16860060
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion.
    Wiebe ER; Trouton K
    Contraception; 2004 Dec; 70(6):463-6. PubMed ID: 15541407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gentle abortion with the pill?].
    Bansbach BA
    MMW Fortschr Med; 1999 Jul; 141(28-29):14. PubMed ID: 10897936
    [No Abstract]   [Full Text] [Related]  

  • 8. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].
    Iamakov K; Pekhlivanov B; Amaliev I
    Akush Ginekol (Sofiia); 2005; 44(3):16-8. PubMed ID: 16028385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
    Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA;
    Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are two doses of misoprostol after mifepristone for early abortion better than one?
    Coyaji K; Krishna U; Ambardekar S; Bracken H; Raote V; Mandlekar A; Winikoff B
    BJOG; 2007 Mar; 114(3):271-8. PubMed ID: 17217359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13-29 weeks.
    Hidar S; Bouddebous M; Chaïeb A; Jerbi M; Bibi M; Khaïri H
    Arch Gynecol Obstet; 2005 Dec; 273(3):157-60. PubMed ID: 16041629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of intravenous oxytocin to vaginal misoprostol for mid trimester labor induction.
    Hidar S; Jerbi M; Khaïri H
    Am J Obstet Gynecol; 2006 Jul; 195(1):332-3; author reply 333-4. PubMed ID: 16813766
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical abortion: the Tunisian experience.
    Hajri S
    Afr J Reprod Health; 2004 Apr; 8(1):63-9. PubMed ID: 15487615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone dose in the regimen with misoprostol for medical abortion.
    Marions L
    Contraception; 2006 Jul; 74(1):21-5. PubMed ID: 16781255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.